Assessment to Identify Predictors of 2-Hour Pain Freedom among Patients Enrolled in 2 Phase 3 Studies of Lasmiditan for Acute Treatment of Migraine

被引：0
|
作者：
Vargas, Bert B. [1 ]
Magis, Delphine [2 ]
Doty, Erin [3 ]
Ruff, Dustin [3 ]
Vasudev, Raghavendra [3 ]
Krege, John H. [3 ]
Hake, Ann [3 ,4 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Dept Neurol, Dallas, TX USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Indiana Univ, Sch Med, Bloomington, IN 47405 USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1763
引用
收藏
页数：3
相关论文
共 50 条
  • [41] BENEFIT OF MULTIPLE INCOBOTULINUMTOXINA INJECTIONS FOR PAIN REDUCTION IN ADULT PATIENTS WITH LIMB SPASTICITY: POOLED ANALYSIS OF PHASE 2/3 STUDIES
    Wissel, J.
    Camoes-Barbosa, A.
    Comes, G.
    Althaus, M.
    Scheschonka, A.
    Simpson, D. M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 76 - 76
  • [42] A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine
    Croop, R.
    Madonia, J.
    Hould, J.
    Mosher, L.
    Lovegren, M.
    Coric, V.
    Lipton, R.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [43] A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine
    Croop, Robert
    Madonia, Jennifer
    Hould, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Lipton, Richard
    [J]. NEUROLOGY, 2023, 100 (17)
  • [44] Genotype Analysis of Patients with Hereditary Factor X Deficiency Enrolled in 2 Phase 3 Studies of Pdfx, a New High-Purity Factor X Concentrate
    Mitchell, Mike
    Kavakli, Kaan
    Norton, Miranda
    Austin, Steve
    [J]. BLOOD, 2015, 126 (23)
  • [45] Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
    Podos, Steven D.
    Trachtman, Howard
    Appel, Gerald B.
    Bomback, Andrew S.
    Dixon, Bradley P.
    Wetzels, Jack F. M.
    Cook, H. Terence
    Parikh, Samir V.
    Pickering, Matthew C.
    Tumlin, James
    Langman, Craig B.
    Lightstone, Liz
    Sperati, C. John
    Daina, Erica
    Bouman, Koenraad Peter
    Rice, Kara
    Thanassi, Jane A.
    Huang, Mingjun
    Nester, Carla
    Remuzzi, Giuseppe
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2023, 53 (10) : 675 - 686
  • [46] A Single-Session, 2-Hour Version of Mindfulness-Oriented Recovery Enhancement (One MORE) Improves Chronic Pain Patients' Pain-Related Outcomes Through 3-Month Follow-Up in a Randomized Controlled Trial
    Hanley, Adam W.
    Lingard, Ayaka
    Garland, Eric L.
    [J]. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2024, 30 (09): : 869 - 877
  • [47] PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES
    Taylor, Peter C.
    van de Laar, Mart
    Curtis, Jeffrey R.
    Azevedo, Valderilio F.
    Luis Rivas, Jose
    Dahl, Palle
    Wang, Lisy
    Iikuni, Noriko
    Shi, Harry
    Woolcott, John
    Benkhalifa, Salim
    Gomez-Reino, Juan Jose
    Dougados, Maxime
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1687 - 1688
  • [48] A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10mg Nasal Spray for the Acute Treatment of Migraine
    Croop, Robert
    Madonia, Jennifer
    Hould, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard B.
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 124 - 125
  • [49] Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
    Croop, Robert
    Madonia, Jennifer
    Stock, David A.
    Thiry, Alexandra
    Forshaw, Micaela
    Murphy, Abigail
    Coric, Vladimir
    Lipton, Richard B.
    [J]. HEADACHE, 2022, 62 (09): : 1153 - 1163
  • [50] TENOFOVIR ALAFENAMIDE (TAF) COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH CHRONIC HBV: WEEK 96 EFFICACY AND SAFETY RESULTS IN CHINESE PATIENTS ENROLLED IN 2 GLOBAL PHASE 3 STUDIES
    Chan, Henry Lik-Yuen
    Seto, Wai Kay
    Fung, Scott
    Hou, Jinlin
    Pan, Calvin
    Chuang, Wan-Long
    Chang, Ting-Tsung
    Hui, Aric-Josun
    Chen, Chi-Yi
    Tsang, Tak Yin Owen
    Yang, Jenny
    Flaherty, John
    Gaggar, Anuj
    Mo, Shuyuan
    Kao, Jia-Horng
    [J]. GUT, 2018, 67 : A302 - A302
12345